ArticleAdvanced healthcare materials2025
Generalizing Gelatin Methacryloyl Granular Hydrogel Fabrication Using Stable Microgels with Predictable Stiffness.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Multifunctional composite microgels: From structural design to biomedical applications.Materials today. Bio · 2026Review
- Orthogonally crosslinked gelatin methacryloyl microgels for in situ assembly of granular hydrogel scaffolds.Bioengineering & translational medicine · 2026Article
- Bioactive granular hydrogels for infection control and immune microenvironment remodeling in wound regeneration.Regenerative biomaterials · 2026Article
- Generalizing Gelatin Methacryloyl Granular Hydrogel Fabrication Using Stable Microgels with Predictable Stiffness.Advanced healthcare materials · 2025Article
- Multiscale Structure-Property Relationships in Gelatin-Based Granular Hydrogel Scaffolds.ACS macro letters · 2025Article
- Micropuncture and granular hydrogel scaffolds to surgically bioengineer a perfusable and stably patterned microvasculature.Angiogenesis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Gelatin methacryloyl (GelMA) granular hydrogel scaffolds (GHS) outperform their bulk, nanoporous hydrogel counterparts in regenerative engineering as a result of cell-scale tunable interconnected void spaces among assembled microgel building blocks. Conventional GelMA GHS fabrication is based on jamming physically crosslinked GelMA microgels below the sol-gel transition temperature, followed by chemical crosslinking to form inter- and intra-microgel covalent bonds. Thus, the in situ formation of GelMA GHS on tissues is impaired by the phase transition (dissolution) of physically crosslinked microgels at the physiological temperature. Partially crosslinked GelMA microgels have been investigated for GHS fabrication, yet a comprehensive understanding of how sequential crosslinking influences microgel characteristics and overall scaffold properties remains unexplored. Free radical photopolymerization is commonly used for GelMA photocrosslinking; however, the tradeoff between microgel stability and covalent assembly remains unknown. Here, GelMA GHS fabrication is generalized using stable microgels via a two-step photocrosslinking approach, and a phase diagram is developed based on the relationships between microgel stability (individual microgel photocrosslinking, step 1) and the scaffold formation capability (photocrosslinking of jammed microgels, step 2). Additionally, a regression model is developed via the Box-Behnken design to predict the mechanical properties of bulk GelMA, resembling the microgels, based on key GHS fabrication variables. This work paves the way for fabricating in situ forming GelMA GHS using stable microgels for a broad range of translational biomedical applications in physiological conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.